
Champions Oncology, Inc.: updates and filings
Price
$4.59
November 17, 2026Market cap $64M
What Ploutos Investor adds for Champions Oncology
Part of Ploutos Investor, €9.99 a month
- The full history: 9 fiscal years, from FY2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Sep 10, 2026next Dec 11, 2026
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
September 2026
July 2026
March 2026
December 2025
October 2025
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 16, 2026Shareholder voteForm8-K
- Sep 11, 2026Quarterly reportfor the period to Jul 31, 2026Form10-Q
- Sep 10, 2026Results of operationsForm8-K
- Aug 28, 2026Additional annual meeting materialFormDEFA14A
- Aug 28, 2026Annual meeting proxy statementFormDEF 14A
- Jul 27, 2026Annual reportfor the period to Apr 30, 2026Form10-K
- Jul 27, 2026Results of operationsForm8-K
- Mar 30, 2026Officer or director changeForm8-K
- Mar 12, 2026Quarterly reportfor the period to Jan 31, 2026Form10-Q
- Mar 12, 2026Results of operationsForm8-K
- Dec 15, 2025Quarterly reportfor the period to Oct 31, 2025Form10-Q
- Dec 15, 2025Results of operationsForm8-K
- Oct 16, 2025Shareholder voteForm8-K
- Sep 15, 2025Quarterly reportfor the period to Jul 31, 2025Form10-Q
- Sep 15, 2025Results of operationsForm8-K
- Aug 22, 2025Additional annual meeting materialFormDEFA14A
- Aug 22, 2025Annual meeting proxy statementFormDEF 14A
- Jul 23, 2025Annual reportfor the period to Apr 30, 2025Form10-K
- Jul 23, 2025Results of operationsForm8-K
- Jul 21, 2025Financial statements and exhibitsForm8-K
- Mar 17, 2025Quarterly reportfor the period to Jan 31, 2025Form10-Q
- Mar 11, 2025Results of operationsForm8-K
- Mar 4, 2025Letter from the SECFormUPLOAD
- Mar 3, 2025Correspondence with the SECFormCORRESP
- Feb 26, 2025Letter from the SECFormUPLOAD
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 16, 2026 | 8-K | Shareholder vote | Document |
| Sep 11, 2026 | 10-Q | Quarterly reportfor the period to Jul 31, 2026 | Document |
| Sep 10, 2026 | 8-K | Results of operations | Document |
| Aug 28, 2026 | DEFA14A | Additional annual meeting material | Document |
| Aug 28, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jul 27, 2026 | 10-K | Annual reportfor the period to Apr 30, 2026 | Document |
| Jul 27, 2026 | 8-K | Results of operations | Document |
| Mar 30, 2026 | 8-K | Officer or director change | Document |
| Mar 12, 2026 | 10-Q | Quarterly reportfor the period to Jan 31, 2026 | Document |
| Mar 12, 2026 | 8-K | Results of operations | Document |
| Dec 15, 2025 | 10-Q | Quarterly reportfor the period to Oct 31, 2025 | Document |
| Dec 15, 2025 | 8-K | Results of operations | Document |
| Oct 16, 2025 | 8-K | Shareholder vote | Document |
| Sep 15, 2025 | 10-Q | Quarterly reportfor the period to Jul 31, 2025 | Document |
| Sep 15, 2025 | 8-K | Results of operations | Document |
| Aug 22, 2025 | DEFA14A | Additional annual meeting material | Document |
| Aug 22, 2025 | DEF 14A | Annual meeting proxy statement | Document |
| Jul 23, 2025 | 10-K | Annual reportfor the period to Apr 30, 2025 | Document |
| Jul 23, 2025 | 8-K | Results of operations | Document |
| Jul 21, 2025 | 8-K | Financial statements and exhibits | Document |
| Mar 17, 2025 | 10-Q | Quarterly reportfor the period to Jan 31, 2025 | Document |
| Mar 11, 2025 | 8-K | Results of operations | Document |
| Mar 4, 2025 | UPLOAD | Letter from the SEC | Document |
| Mar 3, 2025 | CORRESP | Correspondence with the SEC | Document |
| Feb 26, 2025 | UPLOAD | Letter from the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 13, 1995.
The full analysis
What do Champions Oncology's filings show?
The filings are where every one of Champions Oncology's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.